Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)

Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasi...

Full description

Saved in:
Bibliographic Details
Main Authors: Cho, Ah Young, Kim, Dae Hun, Im, Myung, Lee, Young, Seo, Young Joon, Lee, Jeung Hoon
Format: Artigo
Language:Inglês
Published: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276797/
https://ncbi.nlm.nih.gov/pubmed/22346278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2011.23.S3.S360
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items